Baldness, benign prostate hyperplasia, prostate cancer and androgen levels

Aging Male

Volumn 11, Issue 4, 2008, Pages 189-192

  Faydaci, Gökhan ^a,b   Bilal, Eryildirim ^a   Necmettin, Penpegül ^a   Fatih, Tarhan ^a   Asuman, Orcun ^b   Uǧur, Kuyumcuoǧlu ^a  

^a Dr Lutfi Kirdar Kartal Research and Training Hospital   (Turkey)

^b Madalyon Apt No: 17 D:17 ^*  (Turkey)

Author keywords

Androgen level; Baldness; BPH; Prostate cancer

Indexed keywords

ALBUMIN; ANDROGEN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALOPECIA; ANDROGEN BLOOD LEVEL; ARTICLE; BIOAVAILABILITY; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; ESTRADIOL BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL; BLOOD; CHI SQUARE DISTRIBUTION; CLASSIFICATION; MIDDLE AGED; NONPARAMETRIC TEST; PROSTATE TUMOR; RISK FACTOR;

AGED; ALOPECIA; ANDROGENS; CHI-SQUARE DISTRIBUTION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 63249106973     PISSN: 13685538     EISSN: 14730790     Source Type: Journal    
DOI: 10.1080/13685530802400995     Document Type: Article

References (20)

1. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975;68:1359-1365.
2. Whiting DA. Male pattern hair loss: current understanding. Int J Dermatol 1998;37:561-566.
3. Hans W. Male and female androgenetic alopecia. In: Williams H, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, editors. Evidence-based dermatology, 1st edn. London: Blackwell; 2003. pp 571-576.
4. Gann P, Hennekens C, Ma J, Longcope C, Stampfer M. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-1122.
5. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
6. Sawaya ME, Price VH. Different levels of 5alphareductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol 1997;109:296-300.
7. Giltay EJ, Toorians AW, Sarabdjitsingh AR, de Vries NA, Gooren LJ. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol 2004;180:107-112.
8. Parsons JK, Carter HB, Landis P. Higher serum free testosterone is associated with an increased risk of prostate cancer: results from the Baltimore Longitudinal Study on Aging. J Urol 2004;171:116-118.
9. Platz EA, Leitzmann M, Rifai N. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the PSA era. Cancer Epidemiol Biomarkers Prev 2005;14:1262-1269.
10. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous hormones, prostate cancer collaborative group, endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008;100:170- 183.
11. Gann PH, Hennekens CH, Ma J. Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 1996;88:1118-1126.
12. Mohr BA, Feldman HA, Kalish LA, Longcope C, McKinlay JB. Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study. Urology 2001;57:930-935.
13. Mearini L, Costantini E, Zucchi A, Mearini E, Bini V, Cottini E, Porena M. Testosterone levels in benign prostatic hypertrophy and prostate cancer. Urol Int 2008;80:134-140.
14. Olsen EA. Androgenetic alopecia. In: Olsen EA, editor. Disorders of hair growth - diagnosis and treatment. New York: McGraw-Hill; 1994. pp 257-283.
15. Ernest H, Rosalind AB, Barry IG. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey: short communication. Cancer Epidemiology, Biomarkers Prevent 2000;9:523-527.
16. Bong RO, Seong JK, JaI DM, Hyeung NK, Dong DK, Young HW, Soo BR, Yang IP. Association of benign prostatic hyperplasia with male pattern baldness. Urology 1998;51:744- 748.
17. WenChieh C, Chao-Chun Y, Guan-Yu C, Meng-Chie W, Hamm-Ming S, Tzong-Shin T. Patients with a large prostate show a higher prevalence of androgenetic alopecia. Arch Dermatol Res 2004;296:245-249.
18. Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL. Androgenetic alopecia and prostate cancer: findings from an Australian casecontrol study. Cancer Epidemiol Biomarkers Prev 2002;11:549-553.
19. Wendy DW, Joellen MS, Denis T, Samuel ML, Lauren M, Pamela S, David FP, Cary NR, Anderson EE, Walther PJ. Early onset baldness and prostate cancer risk. Cancer Epidemiol Biomarkers Prevent 2000;9:325-328.
20. Demark WW, Lesko SM, Conaway MR, Robertson CN, Clark RV, Lobaugh B, Mathias BJ, Strigo TS, Paulson DF. Serum androgens: associations with prostate cancer risk and hair patterning. J Androl 1997;18:495-500.